Veeda Clinical Research Ltd. IPO

RHP
View
DRHP
View
Open Date

Not Issued

Close Date

Not Issued

Veeda Clinical Research Ltd. IPO Details

Check out the issue details for Veeda Clinical Research Ltd. IPO as disclosed in SEBI.

Price Band

Not Issued

Issue Size

831.6 Cr.

Issue Type

Book Built

Open

Not Issued

Close

Not Issued

Veeda Clinical Research Ltd. News

 IPO news not found.

Company Financials

You can get the following financial statements of Veeda Clinical Research Ltd. as of now.

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

The approx valuation of Veeda Clinical Research IPO based on its price band and DRHP/RHP is:

Particulars Value
Upper Price Band Not issued
Existing Shares (Qty) 4.62 Cr
Fresh Issue 331.6 Cr
EPS (FY21) Rs 15.39

 

Veeda Clinical Research IPO issue size is 831.6 Cr:

Issue Amount
Fresh Issue 331.6 Cr
Offer For Sale 500 Cr

 

The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Maximum 50%
Non-Institutional Minimum 15%
Retail Individual Minimum 35%
Employee  Not Disclosed

The dates for the IPO is not issued yet. Check this space later on.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 218.44 151.27 195.81 223.93 296.15
Total Expenditure 136.14 131.89 129.1 182.85 241.74
Operating Profit 82.31 19.39 66.72 41.08 54.42
Other Income 5.34 2.41 38.57 4.23 9.15
Interest 2.38 5.09 4.81 4.58 5.33
Depreciation 9.44 15.8 14.95 15.53 21.13
Exceptional Items 0 0 0 0 0
Profit Before Tax 75.82 0.9 85.53 25.2 37.1
Provision for Tax 23.2 0.94 22.25 6.87 11.15
Net Profit 52.62 -0.04 63.29 18.33 25.95
Adjusted EPS (Rs.) 0.76 0 1.76 0.35 0.49

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 35.82 35.82 35.83 10.58 10.58
Total Reserves 53.69 52.18 133.93 463.18 510.6
Borrowings 0 0 0 0 0
Other N/C liabilities -0.17 32.47 34.8 27.48 34.54
Current liabilities 39.82 55.57 74.75 88.68 96.4
Total Liabilities 129.17 176.04 279.31 589.91 652.11
Assets
Net Block 37.75 77.66 74.36 69.7 105.72
Capital WIP 7.41 0 0.46 8.84 4.69
Intangible WIP 0.33 0.51 0.67 1.37 3.32
Investments 0 0 37.02 165.13 213.15
Loans & Advances 10.43 17.58 41.38 26.02 25.91
Other N/C Assets 0.4 4.85 4.89 13.7 36.51
Current Assets 72.84 75.44 120.52 305.16 262.82
Total Assets 129.17 176.04 279.31 589.91 652.11
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 75.82 0.9 85.53 25.2 37.1
Adjustment 8.24 19.66 18.34 20.9 32.45
Changes in Assets & Liabilities 14.19 -2.29 -4.22 -21.41 19.07
Tax Paid -23.03 -9.14 -23.03 -11.96 -13.55
Operating Cash Flow 75.23 9.13 76.63 12.73 75.06
Investing Cash Flow -8.63 -8.93 -93.15 -142.07 -107.61
Financing Cash Flow -55.57 -3.45 17.07 172.1 8.15
Net Cash Flow 11.02 -3.25 0.55 42.76 -24.4
X